tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market
Holding VTGN?
Track your performance easily

VistaGen Therapeutics (VTGN) Ownership - Who Owns VistaGen Therapeutics?

803 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,762,480Institution6.33%5,234,566
1,672,480Institution6.01%4,967,266
400,000Insider1.44%1,188,000
256,351Institution0.92%761,362
120,705Institution0.43%358,494
63,032Institution0.23%187,205
55,751Insider0.20%165,580
31,362Insider0.11%93,145
30,142Institution0.11%89,522
23,302Institution0.08%69,207

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,762,480Institution6.33%5,234,566
256,351Institution0.92%761,362
23,302Institution0.08%69,207
19,877Institution0.07%59,035
457Institution<0.01%1,357

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,188,817Institution4.27%3,376,240
483,663Institution1.74%1,373,603
120,705Institution0.43%342,802
63,032Institution0.23%187,205
30,142Institution0.11%85,603

FAQ

Who Owns VistaGen Therapeutics (VTGN)?
Currently, no data Available
What percentage of VistaGen Therapeutics (VTGN) stock is held by institutional investors?
Currently, no data Available
What percentage of VistaGen Therapeutics (VTGN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of VistaGen Therapeutics (VTGN)?
VANGUARD INDEX FUNDS owns the most shares of VistaGen Therapeutics (VTGN).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis